Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Cutting Edge: Protection by Antiviral Memory CD8 T Cells Requires Rapidly Produced Antigen in Large Amounts.

Remakus S, Ma X, Tang L, Xu RH, Knudson C, Melo-Silva CR, Rubio D, Kuo YM, Andrews A, Sigal LJ.

J Immunol. 2018 May 15;200(10):3347-3352. doi: 10.4049/jimmunol.1701568. Epub 2018 Apr 11.


Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection.

Xu RH, Wong EB, Rubio D, Roscoe F, Ma X, Nair S, Remakus S, Schwendener R, John S, Shlomchik M, Sigal LJ.

Immunity. 2015 Dec 15;43(6):1148-59. doi: 10.1016/j.immuni.2015.11.015.


CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.

Fang M, Remakus S, Roscoe F, Ma X, Sigal LJ.

J Virol. 2015 Jan;89(1):776-83. doi: 10.1128/JVI.02176-14. Epub 2014 Oct 29.


Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection.

Rubio D, Xu RH, Remakus S, Krouse TE, Truckenmiller ME, Thapa RJ, Balachandran S, Alcamí A, Norbury CC, Sigal LJ.

Cell Host Microbe. 2013 Jun 12;13(6):701-10. doi: 10.1016/j.chom.2013.04.015.


Memory CD8⁺ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection.

Remakus S, Rubio D, Lev A, Ma X, Fang M, Xu RH, Sigal LJ.

Cell Host Microbe. 2013 May 15;13(5):546-557. doi: 10.1016/j.chom.2013.04.004.


Memory CD8⁺ T cell protection.

Remakus S, Sigal LJ.

Adv Exp Med Biol. 2013;785:77-86. doi: 10.1007/978-1-4614-6217-0_9. Review.


Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease.

Remakus S, Rubio D, Ma X, Sette A, Sigal LJ.

J Virol. 2012 Sep;86(18):9748-59. doi: 10.1128/JVI.00981-12. Epub 2012 Jun 27.


Gamma interferon and perforin control the strength, but not the hierarchy, of immunodominance of an antiviral CD8+ T cell response.

Remakus S, Sigal LJ.

J Virol. 2011 Dec;85(23):12578-84. doi: 10.1128/JVI.05334-11. Epub 2011 Sep 14.


Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response.

Xu RH, Remakus S, Ma X, Roscoe F, Sigal LJ.

PLoS Pathog. 2010 Feb 12;6(2):e1000768. doi: 10.1371/journal.ppat.1000768.

Supplemental Content

Loading ...
Support Center